Long-term follow-up of idiopathic intracranial hypertension: The Iowa experience

Neurology

Volumn 70, Issue 8, 2008, Pages 634-640

  Shah, V A ^a   Kardon, R H ^a,b   Lee, A G ^a   Corbett, J J ^c   Wall, M ^a,b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; FUROSEMIDE;

ADULT; ARTICLE; CEREBROSPINAL FLUID SHUNTING; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; NEUROOPHTHALMOLOGY; OPTIC DISK; PAPILLEDEMA; PRIORITY JOURNAL; UNITED STATES; UNIVERSITY HOSPITAL; VISION; VISUAL FIELD; VISUAL IMPAIRMENT;

EID: 39749173796     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000299893.43918.a8     Document Type: Article

References (15)

1. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988;45:875-877.
2. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993;50:78-80.
3. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension [see comment]. J Neuro-Ophthalmol 2004;24:138-145.
4. Smith JL. Whence pseudotumor cerebri? J Clin Neuro-ophthalmol 1985;5:55-56.
5. Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982;39:461-474.
6. Rowe FJ, Sarkies NJ. Assessment of visual function in idiopathic intracranial hypertension: a prospective study. Eye 1998;12(Pt 1):111-118.
7. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114:155-180.
8. Wall M. Idiopathic intracranial hypertension. Neurol Clin 1991;9:73-95.
9. Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004;63:1737-1739.
10. Arienta C, Caroli M, Balbi S, Parma A, Calappi E, Massei R. Clinical evaluation and long-term follow-up in 16 patients with pseudotumour cerebri. Acta Neurochir Suppl 1990;51:369-371.
11. Bulens C, De Vries >WA, Van Crevel H. Benign intracranial hypertension. A retrospective and follow-up study. J Neurol Sci 1979;40:147-157.
12. Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 1983;33:1386-1388.
13. Bono F, Lupo MR, Serra P, et al. Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology 2002;59:1641-1643.
14. Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry 1982;45:13-18.
15. Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007;143:635-641.